Showing results (1621-1630 of 1,912) with videos related to

Sort By:
Pageof 192
Nature|December 19, 1996
Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agentsR G Kurumbail, A M Stevens, J K Gierse, et al.
Molecular Metabolism|March 18, 2014
Hepatic transforming growth factor-β 1 stimulated clone-22 D1 controls systemic cholesterol metabolismJulia Jäger, Vera Greiner, Daniela Strzoda, et al.
Plos One|January 9, 2016
Dynamics of Urinary Calprotectin after Renal IschaemiaJan Ebbing, Felix S Seibert, Nikolaos Pagonas, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRILily Nguyen, Yuze Song, Anna Dornisch, et al.
Acta Biomaterialia|June 20, 2020
A lean magnesium-zinc-calcium alloy ZX00 used for bone fracture stabilization in a large growing-animal modelPatrick Holweg, Leopold Berger, Martina Cihova, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
Epistasis reduces fitness costs of influenza A virus escape from stem-binding antibodiesChung-Young Lee, Vedhika Raghunathan, C Joaquin Caceres, et al.
Journal of Virology|April 15, 2003
Analysis of the mechanism by which the small-molecule CCR5 antagonists SCH-351125 and SCH-350581 inhibit human immunodeficiency virus type 1 entryFotini Tsamis, Svetlana Gavrilov, Francis Kajumo, et al.
Radiology. Imaging Cancer|January 27, 2023
A Multicompartmental Diffusion Model for Improved Assessment of Whole-Body Diffusion-weighted Imaging Data and Evaluation of Prostate Cancer Bone MetastasesChristopher C Conlin, Christine H Feng, Leonardino A Digma, et al.
Critical Care Medicine|February 16, 2021
von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019Adrian A N Doevelaar, Martin Bachmann, Bodo Hölzer, et al.
Urologic Oncology|December 20, 2024
Risks of grade reclassification among patients with Gleason grade group 1 prostate cancer and PI-RADS 5 findings on prostate MRIVinaik Mootha Sundaresan, Lindsey Webb, Maximilian Rabil, et al.
Pageof 192